Regenix Biosciences Profile
Key Indicators
- Authorised Capital ₹ 16.00 Cr
- Paid Up Capital ₹ 14.38 Cr
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.70 Cr
- Satisfied Charges ₹ 8.70 Cr
- Revenue Growth 158.48%
- Profit Growth 19.45%
- Ebitda 2415.25%
- Net Worth 165.97%
- Total Assets 18.85%
About Regenix Biosciences
Regenix Biosciences Limited (RBL) is a Public Limited Indian Non-Government Company incorporated in India on 02 March 2006 and has a history of 18 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Liv Medica Equipments Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 16.00 Cr and a paid-up capital of Rs 14.38 Cr.
The company currently has active open charges totaling ₹14.70 Cr. The company has closed loans amounting to ₹8.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Regenix Biosciences Limited India are Krishanamoorthy Nirosha as CFO and Srividhya as Company Secretary. Ramamurthy Ayyavuthevar, Ashish Vora, Kannan Jeyabalan, and Seven other members serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TN2006PLC059065
-
Company No.
059065
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 2006
-
Date of AGM
22 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Regenix Biosciences Limited offer?
Regenix Biosciences Limited offers a wide range of products and services, including First Aid Kits, Plastic First Aid Box, Bandages, Surgical Bandage, Protective Sleeves.
Who are the key members and board of directors at Regenix Biosciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramamurthy Ayyavuthevar
|
Managing Director | 02-Mar-2006 | Current |
|
Krishanamoorthy Nirosha
|
CFO | 01-May-2019 | Current |
|
Srividhya
|
Company Secretary | 01-May-2019 | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Manjit Parmar
|
Director | 01-May-2019 | Current |
|
Ashish Vora
|
Director | 01-May-2019 | Current |
|
Kannan Jeyabalan
|
Director | 11-Dec-2007 | Current |
|
Thangasamy Manoharan
|
Director | 11-Dec-2007 | Current |
|
Malathi Ramamurthy
|
Director | 29-Sep-2007 | Current |
|
Selvaraju Thangaiyan
|
Director | 11-Dec-2007 | Current |
Financial Performance of Regenix Biosciences.
Regenix Biosciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 158.48% increase. The company also saw a substantial improvement in profitability, with a 19.45% increase in profit. The company's net worth Soared by an impressive increase of 165.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regenix Biosciences?
In 2023, Regenix Biosciences had a promoter holding of 89.57% and a public holding of 10.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Regenix Super Speciality Laboratories Private LimitedRamamurthy Ayyavuthevar and Malathi Ramamurthy are mutual person
-
Regenix Drugs LimitedRamamurthy Ayyavuthevar, Malathi Ramamurthy and 3 more are mutual person
-
Phantom Digital Effects LimitedManjit Parmar is a mutual person
-
Prime Pharmaceuticals Private LimitedRamamurthy Ayyavuthevar and Ashish Vora are mutual person
-
Odon Prime Pharma Private LimitedAshish Vora is a mutual person
Charges (Loans)
₹14.70 Cr
₹8.70 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 14.50 Cr
- Central Bank Of India : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2021 | Hdfc Bank Limited | ₹14.50 Cr | Open |
| 16 Jun 1983 | Central Bank Of India | ₹2.00 M | Open |
| 18 Aug 2006 | Uti Bank Limited | ₹8.70 Cr | Satisfied |
How Many Employees Work at Regenix Biosciences?
Regenix Biosciences has a workforce of 29 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regenix Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
